Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).
Coppo P, Bubenheim M, Benhamou Y, Völker L, Brinkkötter P, Kühne L, Knöbl P, Mingot-Castellano ME, Pascual-Izquierdo C, de la Rubia J, Del Rio Garma J, Chaturvedi S, Masias C, Mazepa M, Zheng XL, Sinkovits G, Réti M, Patriquin CJ, Pavenski K, Boechat T, Farias J, Oliveira Ribeiro EF, Lobo de Andrade ML, Veyradier A, Joly B, Bouzid R, Sakai K, Matsumoto M, Agosti P, Mancini I, Peyvandi F, Gavriilaki E, Stubbs M, Hmaid A, Cataland S, Lämmle B, Scully M.
Coppo P, et al. Among authors: reti m.
EClinicalMedicine. 2025 Mar 30;82:103168. doi: 10.1016/j.eclinm.2025.103168. eCollection 2025 Apr.
EClinicalMedicine. 2025.
PMID: 40235949
Free PMC article.